PASITHEA THERAPEUTICS CORP. Pre-Tax Income
PASITHEA THERAPEUTICS CORP. (KTTA) reported Pre-Tax Income of -$5.27 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2026-08-14
- PASITHEA THERAPEUTICS CORP. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-06-30 was -$5.27M.
- PASITHEA THERAPEUTICS CORP. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-03-31 was -$2.87M.
- PASITHEA THERAPEUTICS CORP. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-12-31 was -$10.11M.
- PASITHEA THERAPEUTICS CORP. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-09-30 was -$3.04M.
- PASITHEA THERAPEUTICS CORP. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2025 was -$20.43M.
- PASITHEA THERAPEUTICS CORP. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2024 was -$13.90M.
- PASITHEA THERAPEUTICS CORP. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$15.51M.
- PASITHEA THERAPEUTICS CORP. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$11.73M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 5 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 8 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.27M 10-Q · filed 2026-08-14 | -$8.14M 10-Q · filed 2026-08-14 | -$18.25M derived: sum of 3 quarters · filed 2026-08-14 | -$21.29M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2026-03-31 | -$2.87M 10-Q · filed 2026-05-15 | -$12.98M derived: sum of 2 quarters · filed 2026-05-15 | -$16.02M derived: sum of 3 quarters · filed 2026-05-15 | -$19.73M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2025-12-31 | -$10.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$13.15M derived: sum of 2 quarters · filed 2026-03-30 | -$16.86M derived: sum of 3 quarters · filed 2026-08-14 | -$20.43M 10-K · filed 2026-03-30 | ||||||
| 2025-09-30 | -$3.04M 10-Q · filed 2025-11-13 | -$6.75M derived: sum of 2 quarters · filed 2026-08-14 | -$10.32M 10-Q · filed 2025-11-13 | -$13.49M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2025-06-30 | -$3.72M 10-Q · filed 2026-08-14 | -$7.28M 10-Q · filed 2026-08-14 | -$10.46M derived: sum of 3 quarters · filed 2026-08-14 | -$13.46M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2025-03-31 | -$3.56M 10-Q · filed 2026-05-15 | -$6.74M derived: sum of 2 quarters · filed 2026-05-15 | -$9.74M derived: sum of 3 quarters · filed 2026-05-15 | -$13.61M derived: sum of 4 quarters · filed 2026-05-15 | ||||||
| 2024-12-31 | -$3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$6.18M derived: sum of 2 quarters · filed 2026-03-30 | -$10.04M derived: sum of 3 quarters · filed 2026-03-30 | -$13.90M 10-K · filed 2026-03-30 | ||||||
| 2024-09-30 | -$3.00M 10-Q · filed 2025-11-13 | -$6.87M derived: sum of 2 quarters · filed 2025-11-13 | -$10.73M 10-Q · filed 2025-11-13 | -$15.76M derived: sum of 4 quarters · filed 2025-11-13 | ||||||
| 2024-06-30 | -$3.87M 10-Q · filed 2025-08-14 | -$7.73M 10-Q · filed 2025-08-14 | -$12.76M derived: sum of 3 quarters · filed 2025-08-14 | -$16.37M derived: sum of 4 quarters · filed 2025-08-14 | ||||||
| 2024-03-31 | -$3.86M 10-Q · filed 2025-05-15 | -$8.89M derived: sum of 2 quarters · filed 2025-05-15 | -$12.50M derived: sum of 3 quarters · filed 2025-05-15 | -$16.10M derived: sum of 4 quarters · filed 2025-05-15 | ||||||
| 2023-12-31 | -$5.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$8.64M derived: sum of 2 quarters · filed 2025-03-24 | -$12.24M derived: sum of 3 quarters · filed 2025-03-24 | -$15.51M 10-K · filed 2025-03-24 | ||||||
| 2023-09-30 | -$3.61M 10-Q · filed 2024-11-13 | -$7.21M derived: sum of 2 quarters · filed 2024-11-13 | -$10.48M 10-Q · filed 2024-11-13 | -$14.53M derived: sum of 4 quarters · filed 2024-11-13 | ||||||
| 2023-06-30 | -$3.60M 10-Q · filed 2024-08-13 | -$6.86M 10-Q · filed 2024-08-13 | -$10.92M derived: sum of 3 quarters · filed 2024-08-13 | -$15.11M derived: sum of 4 quarters · filed 2024-08-13 | ||||||
| 2023-03-31 | -$3.27M 10-Q · filed 2024-05-14 | -$7.32M derived: sum of 2 quarters · filed 2024-05-14 | -$11.51M derived: sum of 3 quarters · filed 2024-05-14 | -$13.70M derived: sum of 4 quarters · filed 2024-05-14 | ||||||
| 2022-12-31 | -$4.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$8.24M derived: sum of 2 quarters · filed 2024-03-29 | -$10.43M derived: sum of 3 quarters · filed 2024-03-29 | -$11.73M 10-K · filed 2024-03-29 | -$13.94M 10-K · filed 2023-03-30 | |||||
| 2022-09-30 | -$4.19M 10-Q · filed 2023-11-13 | -$4.59M 10-Q · filed 2022-11-14 | -$6.38M derived: sum of 2 quarters · filed 2023-11-13 | -$7.67M 10-Q · filed 2023-11-13 | -$8.82M 10-Q · filed 2022-11-14 | -$7.04M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | -$2.19M 10-Q · filed 2023-08-11 | -$2.66M 10-Q · filed 2022-08-15 | -$3.48M 10-Q · filed 2023-08-11 | -$4.23M 10-Q · filed 2022-08-15 | -$2.85M derived: sum of 3 quarters · filed 2023-08-11 | -$4.38M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | -$1.29M 10-Q · filed 2023-05-12 | -$1.57M 10-Q · filed 2022-05-16 | -$663.44K derived: sum of 2 quarters · filed 2023-05-12 | -$2.19M derived: sum of 3 quarters · filed 2023-05-12 | -$2.92M derived: sum of 4 quarters · filed 2023-05-12 | |||||
| 2021-12-31 | $630.14K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$895.97K derived: sum of 2 quarters · filed 2023-03-30 | -$1.62M derived: sum of 3 quarters · filed 2023-03-30 | -$2.17M 10-K · filed 2023-03-30 | ||||||
| 2021-09-30 | -$1.53M 10-Q · filed 2022-11-14 | -$2.25M derived: sum of 2 quarters · filed 2022-11-14 | -$2.80M 10-Q · filed 2022-11-14 | |||||||
| 2021-06-30 | -$727.95K 10-Q · filed 2022-08-15 | -$1.28M 10-Q · filed 2022-08-15 | ||||||||
| 2021-03-31 | -$549.61K 10-Q · filed 2022-05-16 | |||||||||
| 2020-12-31 | -$40.98K 10-K · filed 2022-03-30 | |||||||||
| 2020-09-30 | -$13.97K 10-Q · filed 2021-11-18 | -$13.97K 10-Q · filed 2021-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |